MedTrace Logo

Gene Expression Profiles in Multiple Sclerosis (MS)

NCT00704834 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2020-02-21

No results posted yet for this study

Summary

The purpose of this study is to test differences in RNA levels between Multiple Sclerosis (MS) patients and normal subjects. RNA provides a "message" from genes altered in diseases. We will also test DNA to determine if there are any small mutations called SNPs in any of the genes. The last tests are two separate tests for markers of inflammation called cytokines and eicosanoids. This research may lead to the discovery of biological markers for MS that are useful for diagnosis and treatment.

Conditions

Interventions

OTHER

Blood Draw

35 cc of peripheral blood will be obtained by venipuncture from each subject.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Michelle Apperson, MD, PhD · University of California, Davis

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2017-07-05
Completion
2017-07-05

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00704834 on ClinicalTrials.gov